| Name | Title | Contact Details |
|---|
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
Wuhan General Group, Inc. through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercialises a range of CBD-based products under the Dr. AnnaRxâ„¢ and Medspressoâ„¢ brands.
Get in shape, build strength, tone, and lose weight, faster with BurnAlong.
Physiotherapy & Sports Medicine is a Montrí©al, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cannus Partners Inc. operates as a specialty pharmaceutical company. The Company cultivates, processes, and distributes cannabis. Cannus Partners serves customers in the United States and Canada.